Kit For The Preparation Of Technetium Tc 99m-labeled Carbon Inhalation Aerosol
NDC Package 73814-986-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Kit For The Preparation Of Technetium Tc 99m-labeled Carbon Inhalation Aerosol aerosols is tECHNEGAS, when used with sodium pertechnetate Tc 99m in the Technegas Plus System, provides technetium Tc 99m-labeled carbon inhalation aerosol (Technegas Aerosol), for use in adults and pediatric patients aged 6 years and older for:• visualization of pulmonary ventilation • evaluation of pulmonary embolism when paired with perfusion imaging. This formulation utilizes a aerosol delivery system. Marketed by Cyclomedica Australia Pty Limited, this product is identified by NDC 73814-986.

Identification & Billing

NDC Package Code
73814-986-20
Package Description
50 AEROSOL in 1 CARTON
Product Code
11-Digit Billing Format
73814098620

Clinical Specifications

Proprietary Name
Kit For The Preparation Of Technetium Tc 99m-labeled Carbon Inhalation Aerosol
Non-Proprietary Name
Kit For The Preparation Of Technetium Tc 99m-labeled Carbon Inhalation Aerosol
Substance Name
Graphite
Dosage Form
Aerosol - A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols).
Active Ingredient(s)
Usage Information
TECHNEGAS, when used with sodium pertechnetate Tc 99m in the Technegas Plus System, provides technetium Tc 99m-labeled carbon inhalation aerosol (Technegas Aerosol), for use in adults and pediatric patients aged 6 years and older for:• visualization of pulmonary ventilation • evaluation of pulmonary embolism when paired with perfusion imaging

Regulatory & Marketing

Labeler Name
Cyclomedica Australia Pty Limited
Product Type
Human Prescription Drug
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
09-29-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

Source: OPPS
Tc-99m graphite crucible
HCPCS Dosage EACH
Units / Pkg 50

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73814-986-20 identifies a specific commercial package of 50 aerosol in 1 carton of Kit For The Preparation Of Technetium Tc 99m-labeled Carbon Inhalation Aerosol (UNFINISHED drug), a human prescription drug labeled by Cyclomedica Australia Pty Limited. This aerosol is formulated for use and contains graphite as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cyclomedica Australia Pty Limited on September 29, 2023. The current certification is valid through December 31, 2027.

How is this Cyclomedica Australia Pty Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73814098620. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73814-986-20
11-Digit CMS (5-4-2)
73814-0986-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.